Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dysphagia Outcomes in Zenker Diverticulum: A Longitudinal POuCH Study.

The Laryngoscope·2025

Same author

Socioeconomic Determinants of Health and Reflux Management: Insights from a Tertiary Medical Center.

The Laryngoscope·2024

Same author

A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis.

The Laryngoscope·2024

Same author

Esophageal Baseline Impedance is Associated with Laryngopharyngeal Reflux and Treatment Response.

The Laryngoscope·2024

Same author

Inhaled fosamprenavir for laryngopharyngeal reflux: Toxicology and fluid dynamics modeling.

Laryngoscope investigative otolaryngology·2024

Same author

In Response to The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus.

The Laryngoscope·2024

Same journal

Obesity and Obstructive Sleep Apnea: Impact on Medical and Surgical Management.

Otolaryngologic clinics of North America·2026

Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026

Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026

Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026

Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026

Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 25, 2026

Construction and Characterization of a Novel Vocal Fold Bioreactor

Construction and Characterization of a Novel Vocal Fold Bioreactor

Published on: August 1, 2014

Medications and Vocal Function.

Jonathan M Bock¹

¹Division of Laryngology and Professional Voice, Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.

Otolaryngologic Clinics of North America

|May 12, 2019

Summary

This summary is machine-generated.

Medications can subtly affect vocal function by altering laryngeal hydration, vocal fold integrity, muscle function, and sensation. This review identifies medication classes causing vocal changes and suggests diagnostic and treatment strategies.

Keywords:

Anticholinergic Antipsychotic Dysphonia Medications Reflux Steroid inhaler

More Related Videos

Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication

Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication

Published on: June 5, 2016

Author Spotlight: Advancements in the Fabrication of Synthetic Vocal Fold Models for Phonetic and Robotic Applications

Author Spotlight: Advancements in the Fabrication of Synthetic Vocal Fold Models for Phonetic and Robotic Applications

Published on: January 5, 2024

Related Experiment Videos

Last Updated: Jan 25, 2026

Construction and Characterization of a Novel Vocal Fold Bioreactor

Construction and Characterization of a Novel Vocal Fold Bioreactor

Published on: August 1, 2014

Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication

Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication

Published on: June 5, 2016

Author Spotlight: Advancements in the Fabrication of Synthetic Vocal Fold Models for Phonetic and Robotic Applications

Author Spotlight: Advancements in the Fabrication of Synthetic Vocal Fold Models for Phonetic and Robotic Applications

Published on: January 5, 2024

Area of Science:

Otolaryngology
Pharmacology
Speech and Language Pathology

Background:

Medications exert diverse effects on laryngeal structures and functions.
These effects can be gradual and difficult to attribute directly to medication use.

Purpose of the Study:

To outline medication classes impacting vocal function.
To identify clinical indicators of medication-induced vocal changes.
To propose management strategies for these vocal alterations.

Main Methods:

Literature review of medications affecting the larynx.
Analysis of clinical symptoms suggestive of medication-related vocal dysfunction.
Synthesis of treatment approaches for medication-induced voice disorders.

Main Results:

Identified general medication classes known to alter vocal fold hydration, mucosal integrity, muscle function, and sensation.
Highlighted key medical history findings that warrant suspicion of medication-related vocal changes.
Provided recommendations for diagnosing and managing medication-induced vocal issues.

Conclusions:

Medication side effects are a significant, often overlooked, cause of voice changes.
Clinicians should consider medication history when evaluating patients with vocal complaints.
Awareness of these effects can lead to improved patient outcomes through targeted interventions.